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Abstract Like all other eukaryal cytosolic seryl-tRNA synthe-
tase (SerRS) enzymes, Saccharomyces cerevisiae SerRS con-
tains a C-terminal extension not found in the enzymes of
eubacterial and archaeal origin. Overexpression of C-terminally
truncated SerRS lacking the 20-amino acid appended domain
(SerRSC20) is toxic to S. cerevisiae possibly because of altered
substrate recognition. Compared to wild-type SerRS the
truncated enzyme displays impaired tRNA-dependent serine
recognition and is less stable. This suggests that the C-terminal
peptide is important for the formation or maintenance of the
enzyme structure optimal for substrate binding and catalysis.
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1. Introduction
Aminoacyl-tRNA synthetases (aaRS) catalyze the highly
speci¢c attachment of amino acids to their cognate tRNAs
by a two-step mechanism. For most aaRS, the activation of
the amino acid substrate by ATP to form an enzyme-bound
aminoacyl-adenylate intermediate (step I) precedes tRNA
binding and transfer of amino acid to the 3P end of the
tRNA (step II). Seryl-tRNA synthetases, class II homodimeric
enzymes, can activate serine without the presence of tRNA
[1,2]. Evidence from crystallographic studies of class II syn-
thetases shows that the adenylate moiety is stably bound in
the active site, lying beneath the CCA end of tRNA [3^6].
This raises the possibility that the formation of the adenylate
intermediate in£uences tRNA binding and aminoacylation
[3,5,6], or that tRNA binding enhances the accuracy of amino
acid substrate selection. The second of these possibilities,
tRNA-dependent amino acid recognition, has been described
previously for several class I and class II synthetases [7,8],
including yeast SerRS [9]. To understand the mechanism by
which this occurs, we have recently generated a number of
SerRS mutants with altered motif 2 loop residues and showed
that these mutations a¡ect tRNA-dependent amino acid rec-
ognition, possibly by interfering with the £exibility of the
motif 2 loop [9].
In contrast to their prokaryotic counterparts, all so far
identi¢ed eukaryotic seryl-tRNA synthetases (Fig. 1) contain
C-terminal extensions abundant in basic amino acids [10]. In
eukaryotes, extra appended domains occur frequently in ami-
noacyl-tRNA synthetases, but their natural role in the cell
remains unclear. While the existence of a multi-synthetase
complex in yeast is controversial [11,12], for some tRNA syn-
thetases in higher eukaryotes an extra domain is believed to be
important for formation of multisynthetase complexes
[11,13,14]. The extensions may be adapted for specialized
RNA-related functions as recently proposed for yeast me-
thionyl- [15] and glutaminyl-tRNA synthetases [16] or may
be involved in stabilizing the enzyme structure and thus im-
portant for optimization of substrate binding, as recently
shown for yeast SerRS [9]. Here we present evidence that
the C-terminal peptide is also required for the tRNA-depend-
ent serine recognition displayed by yeast SerRS. The deletion
of this domain leads to toxicity and protein degradation upon
overproduction of the truncated SerRSC20 mutant in Saccha-
romyces cerevisiae possibly due to the altered mechanism of
substrate recognition.
2. Materials and methods
2.1. Plasmids and strains
The original plasmids pCJ11SES1 and pCJ11SES1C20, containing
the yeast SES1 structural gene and its truncated form, respectively,
have been described [10]. These were used for transformation of
S. cerevisiae strains WCG4a (MATK ura3 leu-3,112 his-11,15),
WCG4-11a (MATK ura3 leu-3,112 his-11,15 pre1-1) and WCG4-11/
22a (MATK ura3 leu-3,112 his-11,15 pre1-1 pre2-2) [17] in order to
study the stability of the expressed proteins in vivo.
2.2. Protein puri¢cation
Wild-type SerRS was puri¢ed from yeast as described [9,10]. In
order to improve separation from endogenous SerRS, the puri¢cation
scheme for SerRSC20, which has decreased a⁄nity for cation ex-
changers, was modi¢ed as follows: pooled MonoQ fractions contain-
ing SerRSC20 were loaded onto a MonoS column in 30 mM potas-
sium phosphate, pH 6.0 and the truncated enzyme was eluted with a
gradient of 0^100 mM potassium phosphate, pH 7.2. The formation
of heterodimers, which eluted between SerRSC20 and SerRS, was also
detected in the chromatographic pro¢le.
2.3. Preparation of tRNASer
The native tRNASer was isolated from total brewer’s yeast tRNA
by serylation of serine isoacceptors, followed by derivatization of
tRNASer by naphthoxylation and puri¢cation by chromatography
on a benzoylated DEAE-cellulose column as described [18]. After
deacylation, puri¢ed tRNASer accepted 1.3 nmol of serine/A260 unit
of tRNA. The synthetic gene tRNASer2 was constructed distal to the
T7 RNA polymerase promoter. After the run-o¡ transcription of the
BstNI-digested DNA template [19,20], tRNA transcript was puri¢ed
by electrophoresis on 12% denaturing polyacrylamide gel. Eluted
tRNA was renatured by heating for 2 min at 80‡C in 10 mM Tris-
HCl, pH 7.2, 2 mM MgCl2 and slow cooling. The speci¢c activity of
in vitro transcribed tRNASer2 was 1.1 nmol/A260 unit.
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2.4. Determination of kinetic parameters
The extent of adenylate formation catalyzed by the puri¢ed en-
zymes was assessed by pyrophosphate exchange at 30‡C [33]. The
reaction conditions were as in [9]. Typical concentrations of the sub-
strate studied (serine or ATP) were 0.1^10UKm, while the other sub-
strate was kept saturated (serine at 5 mM, Mg-ATP at 2 mM (molar
ratio 1:1)). The concentration of enzymes was 50 nM. Aminoacyla-
tion was performed at 30‡C as described previously [10] in reaction
mixtures containing 50 mM Tris-HCl, pH 7.5, 15 mM MgCl2, 4 mM
dithiothreitol. For all kinetic assays, the concentration of the substrate
studied ([14C]serine, Mg-ATP, or tRNASer) were varied from 0.1 to
10UKm. Saturating concentrations of other substrates were: 5 mM
ATP, 10 WM tRNASer (or corresponding amount of unfractionated
brewer’s yeast tRNA which contained approximately 6% of serine
isoacceptors), and 1 mM 14C-labeled serine. Due to the very low
a⁄nity of SerRSC20 for tRNASer transcript, we were not able to
determine the kinetic parameters for serine in the presence of this
tRNA. Enzyme concentrations were 100 nM.
2.5. Western blot analysis
Protein extracts were prepared from WCG4a or WCG4a-11/22 cells
producing wild-type SerRS (pCJ11SES1) or the C-terminal truncated
form SerRCS20 (pCJ11SESC20). 5U106 cells were resuspended in
lysis bu¡er with glass beads and vortexed for 20 s six times followed
by centrifugation at 17 000Ug for 10 min [10]. Approximately 10 Wl of
the supernatants was used for Western blot analysis. The procedure
for Western blot analysis was performed according to [21], except that
proteins were visualized by chemiluminescence (Lumiglo, Kirkegaard
and Perry).
3. Results and discussion
3.1. The structure of seryl-tRNA synthetases and C-terminal
extensions in eukaryotic enzymes
The amino acid sequence alignment of seryl-tRNA synthe-
tases reveals the presence of prominent, highly basic C-termi-
nal extensions in all cytosolic SerRS enzymes of Eukarya,
which are absent from eubacterial and archaeal enzymes
(Fig. 1). The function of this domain has been investigated
only in S. cerevisiae. We have previously shown that a trun-
cated yeast SES1 gene, lacking the 60 base pairs that encode a
20-amino acid C-terminal extension, is able to complement a
yeast SES1 null allele strain [10]. Thus, the C-terminal exten-
sion in SerRS seems to be dispensable for the viability of the
cell. However, removal of the C-terminal peptide a¡ects both
the stability of the enzyme and its a⁄nity for the substrates in
the aminoacylation reaction, indicating its importance in
maintaining the overall structure of SerRS.
Two eubacterial seryl-tRNA synthetases from Escherichia
coli and Thermus thermophilus have been crystallized in com-
plexes with di¡erent substrates [4,22] and subjected to bio-
chemical analyses in order to identify the domains important
for tRNA and amino acid binding [23^25]. Our recent data
have shown close functional resemblance between yeast SerRS
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Fig. 1. Detail of multiple sequence alignment of seryl-tRNA synthetases. Only the C-terminal parts of the proteins are shown. The organisms
with corresponding accession numbers are as follows: Escherichia coli (P09156), Haemophilus in£uenzae (P43833), Coxiella burnettii (P39919),
Mycoplasma genitalium (P47251), Mycoplasma pneumoniae (P75107), Mycobacterium tuberculosis (EMBL Z83864), Thermus thermophilus
(P34945), Synechocystis sp. (P73201), Bacillus subtilis (P37464), Staphyloccocus aureus (P95689), Saccharomyces cerevisiae, putative mitochon-
drial (P38705), Zea mays, mitochondrial (EMBL Y13053), Haloarcula marismortui (EMBL X91007), Methanococcus jannaschii (58477), Metha-
nococcus maripaludis (O30520), Methanobacterium thermoautotrophicum (O27914, O30521), Archaeoglobus fulgidus (O28244), Pyrococcus hori-
koshii (TrEMBL O58441), Saccharomyces cerevisiae (P07284), Shizosaccharomyces pombe (EMBL Z97210), Arabidopsis thaliana (Q39230), Zea
mays (GenBank AJ007665), Caenorhabditis elegans (EMBL Z68882), Homo sapiens P49591). The accession numbers are from SwissProt, except
where indicated. Cytosolic SerRS enzymes of Eukarya have prominent, highly basic C-terminal extensions absent from eubacterial and archaeal
enzymes. Numbers at the right margin denote total number of amino acid residues in the proteins. Multiple alignment of protein sequences
was performed using CLUSTAL_X [40].
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active site residues and analogously positioned amino acids in
their eubacterial counterparts [9]. Thus, the structures of eu-
bacterial SerRS-tRNASer co-crystals are useful models for ra-
tionalizing yeast SerRS structure. Based on the eubacterial
crystallographic [4,22] as well as biochemical and genetic
data from various organisms [2], tRNASer recognition may
be in general attributed to interactions between the synthetase
and tRNA at both the acceptor stem and the long variable
arm. The long variable arm constitutes the principal determi-
nant for recognition of SerRS in all investigated organisms [2].
Its interaction with the N-terminal coiled-coil of one SerRS
subunit, brings the 3P end of tRNA into the active site of
another subunit [4]. The recognition of the acceptor end seems
to be species-speci¢c [2]. The positioning of the 3P end of
tRNA into the active site of the enzyme induces a conforma-
tional change in a motif 2 loop, both in E. coli and in yeast
[5,9]. We wondered whether the C-terminal peptide of yeast
SerRS was involved in this process. In a model structure of
yeast SerRS (not shown), based upon coordinates of SerRS
from T. thermophilus (1ses.pdb), the C-terminal extension of
the yeast enzyme appears to £ip back and interact with the
active site, as predicted according to the thermodynamically
most stable conformation.
3.2. SerRSC20 overproduction is toxic for S. cerevisiae
It has previously been shown that the C-terminal extension
of SerRS strongly in£uences the stability of the protein [10].
In contrast to the wild-type SerRS, attempts to overproduce
the mutant form of SerRS lacking the C-terminal fragment
(SerRSC20) were unsuccessful, although the mRNA levels of
SES1 and SES1C20 were comparable [10]. To further exam-
ine the in vivo stability of SerRS and SerRSC20, Western blot
analysis was performed with cell extracts prepared from wild-
type strain WCG4 [17] overexpressing SerRS (pCJ11SES1) or
the mutant form SerRSC20 (pCJ11SES1C20). The intracellu-
lar levels of the two proteins were analyzed after growth in
selective media containing galactose (plasmid-borne SES1 in-
ducing conditions) for 16 and 24 h (Fig. 2A). The level of full-
length SerRS seems to decrease slightly after prolonged
growth in inducing media, indicating a minor level of degra-
dation of the wild-type protein. The intracellular level of
SerRSC20 after 16 h of induction, on the other hand, is sig-
ni¢cantly lower than that of the wild-type SerRS. After 24 h
only small amounts of SerRSC20 are observed suggesting
rapid degradation of the mutant SerRS protein in the cells.
Whereas it seems that the cells tolerate overproduction of
wild-type SerRS, these data show that SerRS lacking the
C-terminal extension, SerRSC20, is unstable and is subjected
to degradation.
In order to examine whether degradation of SerRSC20 can
be prevented the strain WCG4-11/22a was used, which con-
tains single mutations in two genes encoding components of
the proteasome (pre1-1 pre2-2) [17,26]. The strain was trans-
formed with plasmids pCJ11SES1 and pCJ11SES1C20 and
cell extracts for Western blot analysis were prepared after
growth for 24 and 36 h in selective medium containing gal-
actose (Fig. 2B). In the proteasome-de¢cient background the
full-length form of SerRS seems to be completely stabilized,
since no visible degradation occurred between 24 and 39 h of
induction. The SerRSC20 protein, however, is visible only
after 24 h of induction. After 39 h the truncated protein is
no longer present in its original size (Fig. 2B). In conclusion,
it seems that whereas degradation of SerRS is completely
abolished, proteolysis of the truncated form of SerRS,
although delayed, is still occurring. The appearance of a lower
molecular weight band of the same intensity as the original
SerRSC20 signal after 39 h induction may suggest that limited
proteolysis has taken place rather than complete degradation
of SerRS. The lower molecular weight band is also weakly
present for wild-type SerRS. This potential degradation inter-
mediate may be obtained by cleavage of SerRS molecules in a
proteasome-independent manner. It seems reasonable to con-
clude from these data that the removal of the C-terminal
extension of SerRS may not only lead to instability of the
protein, but also leads to a cytotoxic e¡ect. This interpretation
is in good agreement with the observation that proteasome-
de¢cient cells (pre1-1 and pre1-1 pre2-2) transformed with
pCJ11SES1C20 show strongly reduced growth compared to
the cells producing wild-type SerRS (data not shown).
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Fig. 2. Western blot analysis of SerRS and SerRSC20. WCG4a (A)
or WCG4-11/22a (pre1-1 pre2-2) (B) cells producing wild-type SerRS
(pCJ11SES1) or the C-terminal truncated form SerRCS20
(pCJ11SESC20) were used for Western blotting. Cells were grown
at 30‡C overnight in SC-Leu medium containing glucose (plasmid
born SES1 non-inducing medium). In order to obtain exponential
growing cultures, 106 cells from the overnight culture were diluted
into 5 ml SC-Leu medium containing glucose and allowed to grow
for 6 h (three generations). Thereafter, 106 cells were diluted into
5 ml SC-Leu medium containing galactose (induces plasmid-borne
SES1) and grown at 30‡C. For cell extract preparation 5U106 cells
were removed after 16 and 24 h (A) and 24 and 39 h (B). Also
shown is the chromosomal-encoded wild-type SerRS (cultures grown
under non-inducing conditions). Time: hours of induction of plas-
mid born SES1. Wt: wild-type SerRS (SerRS). C20: SerRSC20.
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3.3. tRNA binding increases thermal stability of SerRS
Full-length SerRS and the SerRSC20 truncation mutant
were puri¢ed to electrophoretic homogeneity and character-
ized in vitro. The involvement of the C-terminal peptide in the
stabilization of the overall enzyme structure was demonstrated
by comparison of the thermal stability of the full-length and
truncated SerRS enzymes. In accordance with our previous
observation [10], SerRSC20 was heat-inactivated much faster
than the wild-type enzyme but the inactivation was more e⁄-
ciently prevented by tRNA binding (Fig. 3). This ¢nding sup-
ports our assumption that proteolysis in vivo is due to folding
of the mutant protein into a less stable conformation, which
may exhibit an altered mechanism of substrate recognition
(see below).
3.4. Kinetic parameters of SerRSC20
In order to examine the impact of truncation on substrate
recognition and catalysis, the kinetic parameters for wild-type
and mutant SerRS were determined independently in the ami-
no acid activation and aminoacylation reactions. We were
primarily interested in determining whether the recently ob-
served mechanism of tRNA-dependent serine recognition
employed by the full-length SerRS [9] is a¡ected by the
removal of the C-terminal peptide. The described mode of
substrate selection strongly depends on the £exibility of the
motif 2 loop, which undergoes a conformational change
possibly induced by positioning of the 3P end of tRNA into
the active site [5,9]. We reasoned therefore that alteration of
the active site structure induced by the lack of interaction
with the C-terminal peptide might in£uence substrate recog-
nition.
As shown in Table 1, there was no di¡erence in the kinetic
parameters for SerRSC20 and SerRS in the amino acid acti-
vation step assayed by ATP-PPi exchange. This indicates the
existence of similar active site conformations in the two pro-
teins prior to tRNA binding. Furthermore, the enzymes were
analyzed for misactivation of several non-cognate amino
acids. No such activity was observed. In accordance with
our previous results [9] the presence of tRNASer enhances
the a⁄nity of SerRS for serine (Table 1). The di¡erences in
the a⁄nities of SerRS for serine, in the absence (ATP-PPi
exchange) and presence (aminoacylation) of tRNASer pre-
pared by transcription in vitro con¢rms the capability of un-
modi¢ed tRNA to modulate the binding of serine. The full-
length SerRS charges tRNASer transcript with only slightly
reduced speci¢city constant (2.7-fold) compared to the native
tRNASer (1.7-fold higher Km and 1.7-fold lower kcat), indicat-
ing that nucleotide modi¢cations make only a small contribu-
tion to recognition by yeast seryl-tRNA synthetase, as already
shown by Himeno et al. [20,27]. SerRSC20, however, exhibits
two important di¡erences in the kinetic parameters for amino-
acylation: it binds native tRNASer with a 2-fold decreased Km
value while its a⁄nity for tRNASer transcript was decreased
7-fold in comparison with SerRS. The di¡erences in a⁄nities
for native tRNA displayed by the mutant and wild-type en-
zyme were even higher when crude yeast tRNA was taken as a
substrate, indicating that in vivo toxicity of SerRSC20 was
not due to inhibition of the charging of tRNASer by non-
cognate tRNAs. However, the higher a⁄nity of C-terminally
truncated SerRSC20 for its cognate tRNA could be a poten-
tial cause of the toxic behavior of the protein when overpro-
duced in S. cerevisiae (see below). The unmodi¢ed tRNASer is
a very poor substrate for SerRSC20 in comparison with the
full-length enzyme. The speci¢city constant for aminoacyla-
tion of tRNASer transcript with SerRSC20 was reduced
20-fold, with a signi¢cant e¡ect on Km for tRNA which was
increased 7-fold. Since recognition by wild-type SerRS does
not require modi¢ed tRNASer (Table 1), it is di⁄cult to pre-
dict whether the lack of the modi¢cation themselves, or the
speci¢c conformation of the tRNA molecule, which may be
altered in the absence of modi¢cations [28], lowers its a⁄nity
for truncated SerRS. It seems that the wild-type enzyme is not
sensitive to subtle changes in tRNA structure, since the main
contribution to the apparent a⁄nity of SerRS for tRNASer
comes from the interaction between the long variable arm
and the N-terminal domain of SerRS. In contrast to E. coli
SerRS [29], the yeast enzyme does not use the global struc-
tural features of its cognate tRNA for discrimination from
other type 2 tRNA species [27]. However, if tRNASer tran-
script has a slightly relaxed conformation, then the position-
ing of its 3P end in the active site of SerRS could be more
£exible. This £exibility may be accommodated by properly
structured full-length SerRS, but not by truncated SerRSC20,
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Fig. 3. tRNA binding greatly increases thermal stability of the en-
zyme. Enzymes were incubated at 42‡C in 50 mM Tris-HCl pH 7.5,
2 mM DTT, 5% glycerol with or without tRNA in excess. At indi-
cated times aliquots were withdrawn and assayed for aminoacyla-
tion activity.
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explaining the di¡erences in the a⁄nities of the two enzyme
forms for the transcript. Based on these experiments, we
would like to propose that the main role of the C-terminal
peptide in yeast SerRS is to ensure the optimal conformation
of the active site for substrate recognition by guiding proper
positioning of the 3P end of tRNA into the active site. Con-
sistent with such an idea is our ¢nding (Table 1) that trunca-
tion of the C-terminal extension in SerRS interferes with
tRNA-dependent serine recognition. Binding of the cognate
tRNA enhances the a⁄nity of wild-type SerRS for serine,
while this mechanism is impaired in the mutant lacking the
C-terminal domain, as shown by comparable Km values for
serine determined during seryl-adenylate formation and in the
aminoacylation reaction. Enhanced accuracy of substrate se-
lection, via tRNA-dependent serine recognition, may espe-
cially help the discrimination from tRNALeu, the other type
2 tRNA in S. cerevisiae. As recently shown by Himeno et al.
[27], only one nucleotide insertion to the long variable arm
confers an e⁄cient serine acceptor activity upon tRNALeu in
vitro.
3.5. Correlation between cellular toxicity and kinetic
parameters
The balance between tRNA and synthetase concentrations
greatly contributes to the precision of aminoacylation in vivo,
as shown in various systems [30^32]. The speci¢c tRNAs are
not present in the cell in substantially larger amounts than
their cognate synthetases [33]. Thus, sequestering of the cog-
nate tRNA is likely to occur upon synthetase overproduction
and cause a tRNA-dependent arrest of cell growth. Even
overproduction of an inactive enzyme that retains its tRNA
binding capacity could starve cells of a speci¢c charged tRNA
species [34]. On the other hand, overexpression of a mutant
synthetase less able to discriminate between tRNAs may result
in misacylation or enhanced, non-productive binding of non-
cognate tRNAs as described for tyrosyl-tRNA synthetase [35^
37].
Since overproduction of SerRSC20 was toxic to the cell
under conditions where wild-type synthetase [10] and a num-
ber of its active site mutants [9] accumulated in the cell to
levels up to 150-fold above the normal quantities, the trunca-
tion of the C-terminal peptide obviously a¡ects substrate rec-
ognition and catalysis. The toxicity of SerRSC20 in vivo was
not due to a defective interaction with cognate tRNA. Indeed,
SerRSC20 charges tRNASer in vitro with a kcat/Km ratio
1.6 times higher than the wild-type synthetase. However, the
2-fold increased a⁄nity of the truncated enzyme for native
tRNASer seems to be a rather small e¡ect to be solely respon-
sible for depletion of the available tRNASer pool. It cannot be
excluded, on the other hand, that the binding of non-cognate
tRNAs, in addition to partly non-productive binding of
tRNASer, contributes to toxicity. Our experiments also suggest
that the impaired ability of SerRSC20 to perform tRNA-de-
pendent serine recognition is strongly correlated with toxic
behavior. As proposed above, the C-terminal peptide is re-
sponsible for positioning the 3P end of tRNA into the active
site of the enzyme, which will then induce the conformational
change in motif 2 loop required to optimize serine binding
site. This may happen either by direct interaction between
the C-terminal peptide of SerRS and the acceptor end of
tRNA, or indirectly whereby the C20-appended domain en-
sures a suitable active site conformation optimal for the bind-
ing of substrates. In this context, the lost ability of the trun-
cated enzyme to exhibit tRNA-dependent serine recognition
could diminish the transfer of serine to tRNA. Our data also
provide evidence that a very de¢ned SerRS conformation is
essential for tRNA recognition: although unmodi¢ed
tRNASer is a good substrate for wild-type SerRS, it is poorly
recognized by SerRSC20. As a result of this low a⁄nity of the
transcript for the mutated enzyme, it was not possible to
determine Km for serine in the aminoacylation reaction.
The toxic behavior of overproduced SerRSC20 was ob-
served in yeast strains which also produce normal endogenous
levels of SerRS. Thus in addition to causing an imbalance in
overproducing cells due to altered interactions with substrates,
the overexpression of mutant enzyme is expected to decrease
the concentration of functional SerRS due to heterodimer
formation. This provides a further example of dominant neg-
ative inhibition, a phenomenon whereby the function of a
wild-type gene product is impaired by a coexpressed mutant
variant of the same gene product [38]. Analogously, it has
been shown that the overexpression of a C-terminal fragment
of E. coli IleRS exerts an inhibitory e¡ect on this monomeric
enzyme, by interfering with its folding [39].
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Table 1
Kinetic parameters of wild-type and truncated SerRS
Enzyme Substrate Km (mol/l) kcat (s31) Rel. kcat/Km
ATP-PPi exchange
Serine SerRS 4.8U1034 2.2 1
Serine SerRSC20 5.0U1034 2.0 0.87
SerRS ATP 4.0U1034 2.6 1
SerRSC20 ATP 4.0U1034 2.1 0.80
Aminoacylation reaction
SerRS total yeast tRNA 1.20U1037 0.55 1
SerRSC20 total yeast tRNA 5.00U1038 0.46 2.0
SerRS serine 6.25U1035 0.50 1
SerRSC20 serine 2.52U1034 0.46 0.23
SerRS native tRNASer 9.70U1038 0.45 1
SerRSC20 native tRNASer 5.10U1038 0.39 1.6
SerRS serine 6.50U1035 0.58 1
SerRSC20 serine 2.81U1034 0.48 0.19
SerRS tRNASer transcript 1.61U1037 0.27 1
SerRSC20 tRNASer transcript 1.12U1036 0.09 0.05
SerRS serine 6.70U1035 0.59
SerRSC20 serine n.d. n.d.
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